These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8021602)
1. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model. Tewari D; Whalley JM; Love DN; Field HJ J Gen Virol; 1994 Jul; 75 ( Pt 7)():1735-41. PubMed ID: 8021602 [TBL] [Abstract][Full Text] [Related]
2. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals. Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474 [TBL] [Abstract][Full Text] [Related]
3. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse. Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414 [TBL] [Abstract][Full Text] [Related]
4. Interactions between equine herpesvirus type 1 and equine herpesvirus type 4: T cell responses in a murine infection model. Azmi M; Field HJ J Gen Virol; 1993 Nov; 74 ( Pt 11)():2339-45. PubMed ID: 8245851 [TBL] [Abstract][Full Text] [Related]
5. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice. Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844 [TBL] [Abstract][Full Text] [Related]
6. Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model. Tewari D; Nair SV; De Ungria MC; Lawrence GL; Hayden M; Love DN; Field HJ; Whalley JM Arch Virol; 1995; 140(4):789-97. PubMed ID: 7794119 [TBL] [Abstract][Full Text] [Related]
7. High level expression of equine herpesvirus 1 glycoproteins D and H and their role in protection against virus challenge in the C3H (H-2Kk) murine model. Stokes A; Cameron RS; Marshall RN; Killington RA Virus Res; 1997 Aug; 50(2):159-73. PubMed ID: 9282781 [TBL] [Abstract][Full Text] [Related]
8. Cell-mediated antiviral response to equine herpesvirus type 1 demonstrated in a murine infection model by means of adoptive transfer of immune cells. Azmi M; Field HJ J Gen Virol; 1993 Feb; 74 ( Pt 2)():275-80. PubMed ID: 8381468 [TBL] [Abstract][Full Text] [Related]
9. Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice. Packiarajah P; Walker C; Gilkerson J; Whalley JM; Love DN Vet Microbiol; 1998 Apr; 61(4):261-78. PubMed ID: 9646476 [TBL] [Abstract][Full Text] [Related]
10. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Osterrieder N; Wagner R; Brandmüller C; Schmidt P; Wolf H; Kaaden OR Virology; 1995 Apr; 208(2):500-10. PubMed ID: 7747423 [TBL] [Abstract][Full Text] [Related]
11. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1. Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of equine herpesvirus 1 glycoproteins expressed in insect cells. Whalley JM; Love DN; Tewari D; Field HJ Vet Microbiol; 1995 Sep; 46(1-3):193-201. PubMed ID: 8545956 [TBL] [Abstract][Full Text] [Related]
13. Protective effects of intranasal immunization with recombinant glycoprotein d in pregnant BALB/c mice challenged with different strains of equine herpesvirus 1. Fuentealba NA; Zanuzzi CN; Scrochi MR; Sguazza GH; Bravi ME; Cid de la Paz V; Corva SG; Portiansky EL; Gimeno EJ; Barbeito CG; Galosi CM J Comp Pathol; 2014 Nov; 151(4):384-93. PubMed ID: 25124330 [TBL] [Abstract][Full Text] [Related]
14. A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naïve and infection-primed mice. Ruitenberg KM; Walker C; Love DN; Wellington JE; Whalley JM Vaccine; 2000 Jan; 18(14):1367-73. PubMed ID: 10618534 [TBL] [Abstract][Full Text] [Related]
15. DNA-mediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model of EHV-1 respiratory infection. Ruitenberg KM; Walker C; Wellington JE; Love DN; Whalley JM Vaccine; 1999 Jan; 17(3):237-44. PubMed ID: 9987159 [TBL] [Abstract][Full Text] [Related]
16. Study of the protective immunity of co-expressed glycoprotein H and L of equine herpesvirus-1 in a murine intranasal infection model. Kukreja A; Love DN; Whalley JM; Field HJ Vet Microbiol; 1998 Feb; 60(1):1-11. PubMed ID: 9595623 [TBL] [Abstract][Full Text] [Related]
17. Protective immunity against equine herpesvirus type-1 (EHV-1) infection in mice induced by recombinant EHV-1 gD. Zhang Y; Smith PM; Tarbet EB; Osterrieder N; Jennings SR; O'Callaghan DJ Virus Res; 1998 Jul; 56(1):11-24. PubMed ID: 9784062 [TBL] [Abstract][Full Text] [Related]
18. TLR-5 agonist Salmonella abortus equi flagellin FliC enhances FliC-gD-based DNA vaccination against equine herpesvirus 1 infection. Zhao Y; Chang J; Zhang B; Tong P; Wang C; Ran D; Su Y Arch Virol; 2019 May; 164(5):1371-1382. PubMed ID: 30888564 [TBL] [Abstract][Full Text] [Related]
19. Cytokine profiles and long-term virus-specific antibodies following immunization of CBA mice with equine herpesvirus 1 and viral glycoprotein D. Zhang Y; Smith PM; Frampton AR; Osterrieder N; Jennings SR; O'Callaghan DJ Viral Immunol; 2003; 16(3):307-20. PubMed ID: 14583146 [TBL] [Abstract][Full Text] [Related]
20. Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models. Tsujimura K; Yamanaka T; Kondo T; Fukushi H; Matsumura T J Vet Med Sci; 2006 Oct; 68(10):1029-38. PubMed ID: 17085880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]